Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...

Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...